Effect of polyethylene glycol-based preservation solutions on graft injury in experimental kidney transplantation

British Journal of Surgery

Volumn 98, Issue 3, 2011, Pages 368-378

  Thuillier, R ^a,b,c   Renard, C ^d   Rogel Gaillard, C ^d   Demars, J ^e   Milan, D ^e   Forestier, L ^f   Ouldmoulene, A ^f   Goujon, J M ^a   Badet, L ^a,c,h,i   Hauet, T ^b,c,g  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c Fédération Pour LÉtude de LIschémie Reperfusion en Transplantation   (France)

^d UNIVERSITÉ DE LIMOGES   (France)

^e CEMAGREF   (France)

^f CNRS   (France)

^g Domaine du Magneraud   (France)

^h UNIVERSITÉ LYON 1   (France)

ⁱ CENTAURE Network   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; HYDROXYETHYL STARCH FREE UNIVERSITY OF WISCONSIN SOLUTION; HYDROXYETHYL STARCH-FREE UNIVERSITY OF WISCONSIN SOLUTION; MACROGOL DERIVATIVE; PRESERVATION SOLUTION;

ANIMAL; ARTICLE; CHEMISTRY; CONVALESCENCE; DRUG EFFECT; FIBROSIS; GRAFT SURVIVAL; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MACROPHAGE; MALE; METHODOLOGY; PATHOLOGY; REPERFUSION INJURY; SWINE; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD3; BLOTTING, WESTERN; FIBROSIS; GRAFT SURVIVAL; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MACROPHAGES; MALE; ORGAN PRESERVATION SOLUTIONS; POLYETHYLENE GLYCOLS; RECOVERY OF FUNCTION; REPERFUSION INJURY; SWINE;

EID: 79251508009     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7332     Document Type: Article

References (66)

1. Salahudeen AK,. Cold ischemic injury of transplanted kidneys: new insights from experimental studies. Am J Physiol Renal Physiol 2004; 287: F181-F187.
2. Salahudeen AK,. Cold ischemic injury of transplanted organs: some new strategies against an old problem. Am J Transplant 2004; 4: 1.
3. Dragun D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, et al., Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 2000; 58: 2166-2177.
4. Cassie S, Masterson MF, Polukoshko A, Viskovic MM, Tibbles LA,. Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic Biol Med 2004; 36: 1102-1111.
5. Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV,. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153: 557-566.
6. Maathuis MH, Leuvenink HG, Ploeg RJ,. Perspectives in organ preservation. Transplantation 2007; 83: 1289-1298.
7. Jamieson RW, Friend PJ,. Organ reperfusion and preservation. Front Biosci 2008; 13: 221-235.
8. Contractor HH, Johnson PR, Chadwick DR, Robertson GS, London NJ,. The effect of UW solution and its components on the collagenase digestion of human and porcine pancreas. Cell Transplant 1995; 4: 615-619.
9. Jamieson NV, Lindell S, Sundberg R, Southard JH, Belzer FO,. An analysis of the components in UW solution using the isolated perfused rabbit liver. Transplantation 1988; 46: 512-516.
10. Belzer FO, Southard JH,. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45: 673-676.
11. Rauen U, de Groot H,. New insights into the cellular and molecular mechanisms of cold storage injury. J Investig Med 2004; 52: 299-309.
12. Hüter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, et al., Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009; 13: R23.
13. Hauet T, Goujon JM, Baumert H, Petit I, Carretier M, Eugene M, et al., Polyethylene glycol reduces the inflammatory injury due to cold ischemia/reperfusion in autotransplanted pig kidneys. Kidney Int 2002; 62: 654-667.
14. Cau J, Favreau F, Tillement JP, Lerman LO, Hauet T, Goujon JM,. Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: a dose effect study. J Vasc Surg 2008; 47: 852-860.
15. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, et al., The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285: 221-227. (Pubitemid 29329988)
16. Hauet T, Eugene M,. A new approach in organ preservation: potential role of new polymers. Kidney Int 2008; 74: 998-1003.
17. Murad KL, Gosselin EJ, Eaton JW, Scott MD,. Stealth cells: prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood 1999; 94: 2135-2141.
18. Gallucci S, Matzinger P,. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13: 114-119.
19. Faure JP, Baumert H, Han Z, Goujon JM, Favreau F, Dutheil D, et al., Evidence for a protective role of trimetazidine during cold ischemia: targeting inflammation and nephron mass. Biochem Pharmacol 2003; 66: 2241-2250.
20. Hauet T, Goujon JM, Vandewalle A, Baumert H, Lacoste L, Tillement JP, et al., Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol 2000; 11: 138-148.
21. Jayle C, Favreau F, Zhang K, Doucet C, Goujon JM, Hebrard W, et al., Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol 2007; 292: F1082-F1093.
22. Perrault LP, Aubin MC, Malo O, Thollon C, Villeneuve N, Vilaine JP, et al., Status of the endothelium-derived hyperpolarizing factor pathway in coronary arteries after heterotopic heart transplantation. J Heart Lung Transplant 2007; 26: 48-55.
23. Grimm PC, Nickerson P, Gough J, McKenna R, Stern E, Jeffery J, et al., Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 2003; 14: 1662-1668.
24. Dixon IM, Hao J, Reid NL, Roth JC,. Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters. Cardiovasc Res 2000; 46: 286-297.
25. Zhu XY, Chade AR, Krier JD, Daghini E, Lavi R, Guglielmotti A, et al., The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 2009; 27: 2063-2073.
26. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al., Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760. (Pubitemid 351347767)
27. Louapre P, Grongnet JF, Tanguay RM, David JC,. Effects of hypoxia on stress proteins in the piglet heart at birth. Cell Stress Chaperones 2005; 10: 17-23.
28. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
29. Geoffrey R, Norman DLS, (eds). Biostatistics: the Bare Essentials. Mosby-Year Book: St Louis, 1993.
30. Kaplan B,. Overcoming barriers to long-term graft survival. Am J Kidney Dis 2006; 47 (Suppl 2): S52-S64.
31. Baid-Agrawal S, Frei UA,. Living donor renal transplantation: recent developments and perspectives. Nat Clin Pract Nephrol 2007; 3: 31-41.
32. Cecka JM,. The UNOS Scientific Renal Transplant Registry-2000. Clin Transpl 2000; 1-18.
33. Liu Y,. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222.
34. Liu Y,. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12.
35. Eugene M,. Polyethyleneglycols and immunocamouflage of the cells tissues and organs for transplantation. Cell Mol Biol (Noisy-le-Grand) 2004; 50: 209-215.
36. Le Y, Scott MD,. Immunocamouflage: the biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) (mPEG). Acta Biomater 2010; 6: 2631-2641.
37. Bedi S, Vidyasagar A, Djamali A,. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplantation Rev (Orlando) 2008; 22: 1-5.
38. Nankivell BJ, Chapman JR,. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006; 81: 643-654.
39. Faure JP, Jayle C, Dutheil D, Eugene M, Zhang K, Goujon JM, et al., Evidence for protective roles of polyethylene glycol plus high sodium solution and trimetazidine against consequences of renal medulla ischaemia during cold preservation and reperfusion in a pig kidney model. Nephrol Dial Transplant 2004; 19: 1742-1751.
40. Goujon JM, Vandewalle A, Baumert H, Carretier M, Hauet T,. Influence of cold-storage conditions on renal function of autotransplanted large pig kidneys. Kidney Int 2000; 58: 838-850.
41. Hauet T, Goujon JM, Vandewalle A,. To what extent can limiting cold ischaemia/reperfusion injury prevent delayed graft function? Nephrol Dial Transplant 2001; 16: 1982-1985.
42. Hertig A, Anglicheau D, Verine J, Pallet N, Touzot M, Ancel PY, et al., Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 2008; 19: 1584-1591.
43. Strutz FM,. EMT and proteinuria as progression factors. Kidney Int 2009; 75: 475-481.
44. Djamali A, Reese S, Yracheta J, Oberley T, Hullett D, Becker B,. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant 2005; 5: 500-509.
45. Yard BA, Chorianopoulos E, Herr D, van der Woude FJ,. Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant 2001; 16: 1769-1775.
46. Wang W, Koka V, Lan HY,. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005; 10: 48-56.
47. Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH,. Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 2006; 20: 1898-1900.
48. Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP,. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 2000; 58: 1841-1850.
49. Kalluri R, Neilson EG,. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784.
50. Grotendorst GR,. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997; 8: 171-179.
51. Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, et al., Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006; 6: 2292-2306.
52. Copeland JW, Beaumont BW, Merrilees MJ, Pilmore HL,. Epithelial-to- mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 2007; 83: 809-814.
53. Djamali A, Samaniego M,. Fibrogenesis in kidney transplantation: potential targets for prevention and therapy. Transplantation 2009; 88: 1149-1156.
54. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et al., BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968.
55. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, et al., Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-3820.
56. Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S, et al., Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 2009; 75: 1278-1287.
57. Haase VH,. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: F271-F281.
58. Higgins DF, Kimura K, Iwano M, Haase VH,. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008; 7: 1128-1132.
59. Eddy AA,. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301.
60. Haase VH,. Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int 2009; 76: 492-499.
61. Haase VH,. Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis. Ann N Y Acad Sci 2009; 1177: 57-65.
62. Tanaka T, Nangaku M,. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 43-50.
63. Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, et al., Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008; 295: F1023-F1029.
64. Rosenberger C, Pratschke J, Rudolph B, Heyman SN, Schindler R, Babel N, et al., Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies. J Am Soc Nephrol 2007; 18: 343-351.
65. Badet L, Abdennebi HB, Petruzzo P, McGregor B, Espa M, Hadj-Aissa A, et al., [Evaluation of IGL-1, a new organ preservation solution: preclinical results in renal transplantation.] Prog Urol 2005; 15: 481-488.
66. Dutheil D, Rioja-Pastor I, Tallineau C, Goujon JM, Hauet T, Mauco G, et al., Protective effect of PEG 35 000 Da on renal cells: paradoxical activation of JNK signaling pathway during cold storage. Am J Transplant 2006; 6: 1529-1540.